Application Information

This drug has been submitted to the FDA under the reference 009296/002.

Names and composition

"SERPASIL-APRESOLINE" is the commercial name of a drug composed of HYDRALAZINE HYDROCHLORIDE and RESERPINE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
009296/002 SERPASIL-APRESOLINE HYDRALAZINE HYDROCHLORIDE; RESERPINE TABLET/ORAL 50MG and 0.2MG
009296/004 SERPASIL-APRESOLINE HYDRALAZINE HYDROCHLORIDE; RESERPINE TABLET/ORAL 25MG and 0.1MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
009296/002 SERPASIL-APRESOLINE HYDRALAZINE HYDROCHLORIDE; RESERPINE TABLET/ORAL 50MG and 0.2MG
009296/004 SERPASIL-APRESOLINE HYDRALAZINE HYDROCHLORIDE; RESERPINE TABLET/ORAL 25MG and 0.1MG
084617/001 DRALSERP HYDRALAZINE HYDROCHLORIDE; RESERPINE TABLET/ORAL 25MG and 0.1MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved